Sign in

CIK 0001623526

  • Non-accelerated filer
  • Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471144582
Phone
+1 781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$403,975
in 4 filings, $404K under 10b5-1 plans

Net −$403,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-03 Burstein Jennifer Director Grant or award · Director Stock Option (Right to Buy) +17,786 17,786
2025-06-03 Burstein Jennifer Director Grant or award · Director Stock Option (Right to Buy) +29,747 29,747
2024-06-05 Burstein Jennifer Director Grant or award · Director Stock Option (Right to Buy) +7,639 7,639
2023-06-13 Burstein Jennifer Director Grant or award · Director Stock Option (Right to Buy) +19,441 19,441
2022-06-07 Burstein Jennifer Director Grant or award · Director Stock Option (Right to Buy) +21,000 21,000
2021-06-08 Burstein Jennifer Director Grant or award · Director Stock Option (Right to Buy) +11,650 11,650
2020-06-03 Burstein Jennifer Director Grant or award · Director Stock Option (Right to Buy) +14,777 14,777
2019-09-10 Burstein Jennifer Director Grant or award · Director Stock Option (Right to Buy) +29,555 29,555

Page 1 of 1 · 8 trades